19 - PK of RENAL DISEASE Flashcards
Age & CKD
- Renal plasma flow declines with age
- 600ml/min –> 350-450 ml/min
-
Linear Decrease in GFR 0.4-1.02 ml/min
- PER YEAR
- Elderly have a Falsely Elevated GFR
- if have a lack of muscle mass
- due to creatinine
Falsely Elevated GFR
for Elderly
Creatinine decreases due to lower muslce mass
Low Serum creatinine (SCr) shows
a greater creatinine clearance (CrCl)
–> Falsely Elevated GFR
Uremia
-
GFR is impaired due to:
-
Increased Fluid
- –> INCREASED Vd
- Accumalation of TOXINS
-
Increased Fluid
- Reduced GFR & Reduced Active Secretion
-
Uremic patients must have dosage adjustment
- F / Vd / CL are affected
Methods of Renal Excretion
Drug Filtration Rate =
GFR x free fraction of drug x drug concentration
- Glomerular Filtration
- All drugs + metabolites
- PROTEIN BINDING
- Renal tubular secretion
- No protein binding influence
- COMPETITION w/ other drugs
-
Reabsorption
- AFFECTS IONS
- affects acids/bases
- AFFECTS IONS
CKD Stages
<60 GFR
(mL/min/1.73m2)
Diagnosed with CKD
- There is G1-G5
-
G3 has a split = G3a &G3b
- this is where u are diagnosed with CKD
-
G3 has a split = G3a &G3b
Normal GFR
mL/min/m2
120-130 mL/min/m2
Declines with age
70+ years old avg GFR = 75
- 1.1/min of blood flows through kidney
- 20% of cardiac output
- 10% if filtered thru glomerulus
Inulin
- More exact measurement of GFR vs CrCl
- but is more expensive
- is std of practice but not used that often.
Creatinine Clearance
ml/min
NOT EQUAL TO GFR
OVERESTIMATES ACTUAL GFR
small amount creatinine eliminated by secretion/non-renally
- Most often used as a measurement of GFR
- but Varies w/ age/gender/weight
- Best to measure 24-hour urine collection
- Based on Cockcroft-Gault Equation
CrCl
Used Carefully in which populations?
-
Elderly / Malnourished
-
low muscle mass -> low SCr
- –> Falsely Increased CrCl
-
low muscle mass -> low SCr
- Obese
-
Body Builders
-
HIGH muscle mass -> HIGH SCr
- –> Falsely low CrCl
-
HIGH muscle mass -> HIGH SCr
IBW for males
50 + 2.3 (#inches over 5 feet)
IN KILOGRAMS
IBW for Females
45.5 + 2.3 (#inches over 5 feet)
IN KILOGRAMS
Cockcroft Gault Equation
CrCl
ClCr = (140-age) x IBW(kg)
72 x SCr
Multiply by 0.85 if female
Problems with Cockcroft-Gault
- Study was mainly with caucasian males
- NOT GOOD for very small or Very obese patients
- OVERESTIMATES GFR by 10-20%
-
Does NOT account for BSA
*
MDRD Equation
Modification of Diet in Renal Disease
eGFR (estimated GFR, also in mL/min/m2)
More accurate than Cockcroft Gault (CrCl)
Can calculate BSA for very small/obese patients
- Larger and more diverse study
- Limitations:
- Can not be used when SCr is NOT stable
- UNDERESTIMATES eGFR @ normal levels
- OVERestimates eGFR when <20
CKD-EPI Equation
Most Accurate Estimator of eGFR
-
More accurate than MDRD
- but limited # of elderly & ethnic minorities
- Better for patients with HIGHER GFR than MDRD
Adjusted Body Weight
Adj BW
Adj BW = IBW + 0.4(Actual BW - IBW)
Used if Actual BW >30% of IBW
CKD’s Affect on Kinetic Parameters
ORAL BIOAVAILABILITY
-
Reduce Bioavailabilty (F)
- Reduced by altered GI motility
- Altered pH
- Increase in Acidity
- Decreased Liver Function
CKD’s Affect on Kinetic Parameters
Volume of Distribution
Vd
-
INCREASE in fluid/ Vd
- Depends on drug-protein binding
- High Uremic patients hold onto more water as kidney loses function
- –> Increase Vd
- Lower levels of Albumin
- MAY Need to Increase loading dose for CKD patients
Small Vd Drugs
<0.7 L/kg
HIGHLY DIALYZABLE
Highly Water Soluble Drugs
Aminoglycosides / beta lactam antibiotics
Large Vd Drugs
>0.7 L/kg
NOT READILY DIALYZED
-
Lipid-Soluble Drugs
- Fluoroquinolones / macrolides
- Highly Tissue Bound drugs
-
Highly Protein bound drugs
- Phenytoin / Warfarin
Protein Binding & Vd
for CKD patients
CKD Patients may eliminate Albumin in urine
-
DECREASE protein synthesis (protein spill)
- Due to decreased protein intake
- Poor apititite –> lower albumin
-
–> Increase in free drug
- –> possible toxicity
-
–> Increase in free drug
-
Alterations @ tissue binding sites
- Uremic toxins –> bind to receptor sites
- –> Increase in nitrogen metabolites
- Uremic toxins –> bind to receptor sites
Modified Loading Dose
Vd of CKD patient
Modified LD = (Pt’s Vd / Normal Vd) x Ld x weight
Pt’s Vd = Vd of CKD Patient = 0.3-0.35 L/kg
Bioavailability in CKD Patients
-
REDUCED Bioavailability
-
Slowed absorption
- -edema
- Concurrant medications
- Binders for dialysis patients
-
ALKALINE ENVIRONMENT
- Basic due to PPI’s -/-> blocking acidity
-
Slowed absorption
Protein Binding in CKD
-
Decreased Protein Binding
-
Less albumin –> MORE free drug
- –> posible toxicity
- HIGHLY protein bound drugs
- have a low Vd
- because not much protein to bind
-
Less albumin –> MORE free drug